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Abstract 
Mitochondrial dysfunction and oxidative stress are the major events that lead to the formation of 
mitochondrial permeability transition pore (mPTP) during glutamate-induced cytotoxicity and cell 
death. Coenzyme Q10 (CoQ10) has widely been used for the treatment of mitochondrial disorders and 
neurodegenerative diseases. Comparing to traditional lipid-soluble CoQ10, water soluble CoQ10 
(Ubisol-Q10) has high intracellular and intra-mitochondrial distribution. The aims of the present study 
are to determine the neuroprotective effects of Ubisol-Q10 on glutamate-induced cell death and to 
explore its functional mechanisms. HT22 neuronal cells were exposed to glutamate. Cell viability was 
measured and mitochondrial fragmentation was assessed by mitochondrial imaging. The mPTP opening 
was determined by mitochondrial membrane potential and calcium retention capacity. The results 
revealed that the anti-glutamate toxicity effects of Ubisol-Q10 was associated with its ability to block 
mitochondrial fragmentation, to maintain calcium retention capacity and mitochondrial membrane 
potential, and to prevent mPTP formation, AIF release, and DNA fragmentation. We concluded that 
Ubisol-Q10 protects cells from glutamate toxicity by preserving the integrity of mitochondrial structure 
and function. Therefore, adequate CoQ10 supplementation may be beneficial in preventing cerebral 
stroke and other disorders that involve mitochondrial dysfunction. 
Key words: Coenzyme Q10, glutamate toxicity, neuronal cell death, AIF, mitochondrial fragmentation, calcium 
retention. 
Introduction 
Mitochondrial dysfunction due to glutamate 
toxicity is one of the major events that accelerates 
neuronal cell death during acute brain injury such as 
ischemia/stroke, traumatic brain injury, and chronic 
neurodegenerative diseases including Alzheimer 
disease, Parkinson’s disease, and amyotrophic lateral 
sclerosis [1]. Mitochondrial dysfunction due to 
glutamate toxicity is mediated by receptor-initiated 
excitotoxicity [2, 3] and non-receptor mediated 
oxidative toxicity as a result of depletion of 
intracellular cysteine and glutathione [4]. This leads to 
excessive accumulation of reactive oxygen species, 
resulting in oxidative stress [4, 5]. Emerging evidence 
indicates that oxidative stress due to excessive 
generation of reactive oxygen species can affects 
mitochondria adversely [6]. Mitochondrial 
dysfunction releases various factors including 
cytochrome c, apoptosis-inducing factor (AIF), 
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Smac/Diablo (second mitochondria-derived activator 
of caspase/direct IAP binding protein with low PI), or 
endonuclease G which are responsible for activation 
of caspase-dependent or caspase-independent 
mechanisms of DNA degradation and cell death [7]. 
One of the major sites of reactive oxygen species 
(ROS) production in the cell is the mitochondria. 
Mitochondrial ROS is produced upon leakage of 
electrons through complex I (NADH-ubiquinone 
oxidoreductase) or III (ubiquinone-cytochrome c 
oxidoreductase) of the mitochondrial respiratory 
chain [8]. The products of this leakage are superoxide 
anions and hydrogen peroxide. Superoxide is 
converted by the antioxidant enzyme superoxide 
dismutase (SOD) into hydrogen peroxide in the 
mitochondria (SOD2 or MnSOD) or in the cytosol 
(SOD1 or CuZnSOD). Hydrogen peroxide is further 
simplified to water by glutathione peroxidase. 
Oxidative stress due to depletion of antioxidant or 
excessive accumulation of ROS has detrimental effect 
on mitochondrial structure and function. Moreover, 
oxidative stress and mitochondrial dysfunction are 
the primary events in glutamate-induced toxicity [9].  
Mitochondria in healthy neurons resemble long, 
yet remarkably dynamic filaments undergoing cycles 
of mitochondrial fission and fusion events. Fission 
processes are regulated by dynamin-related protein 1 
(Drp1), Mitochondrial fission 1 protein (Fis1), and 
endophilin B1 (Endo B1); while fusion process is 
mediated by mitofusin-1 and -2 (Mfn1, -2) and optic 
atrophy 1 (OPA1) [10]. Disturbance in mitochondrial 
dynamics toward continuous fission leads to 
mitochondrial fragmentation, formation of mPTP, and 
activation of apoptosis and neurodegeneration 
[11-15]. Drp1, which induces mitochondrial fission, 
has been reported to stimulate Bid-induced Bax 
oligomerization and cytochrome c release by 
promoting tethering and hemifusion of membranes 
[16]. Bax knockdown drastically inhibited the 
mitochondrial accumulation of Drp 1 and Drp1 
knockdown attenuated cell apoptosis [17]. Drp1/Bax 
activation promotes mitochondrial fragmentation, 
reduces mitochondrial number, and activates 
apoptotic cell death [18]. We have recently 
demonstrated that glutamate exposure induces 
mitochondrial fragmentation [5]. It is not clear 
whether coenzyme Q10 (CoQ10) is capable of 
preventing mitochondrial fragmentation caused by 
glutamate exposure. 
Ubiquinone CoQ10 (coenzyme Q10, CoQ10) is a 
well-known electron transporter of the mitochondrial 
respiratory chain that shuttles electrons from complex 
I and II (succinate-ubiquinone oxidoreductase) to 
complex III during oxidative phosphorylation and 
energy production. It is normally synthesized in the 
body. However, the levels of CoQ10 decrease with 
genetic mutation, cancer, ageing in human and animal 
tissues. Whole body concentration of CoQ10 is also 
affected by certain drugs such as statins that inhibit 
the synthesis of CoQ10 in patients with a risk of 
cardiovascular diseases and stroke [19-21]. Deficiency 
of CoQ10 can cause varying clinical syndromes, 
including encephalomyopathy, mental retardation, 
recurrent myoglobinuria, isolated myopathy, etc. 
[22-24]. Supplementation of CoQ10 can restore 
normal mitochondrial concentration levels in aging 
[25-27]. Available evidence suggests that besides the 
above essential role, CoQ10 also acts as a ubiquitous 
free radical scavenger and has been shown to 
ameliorate cell death and protects cells under various 
stress conditions including neurodegeneration 
diseases [25, 28, 29]. Although, it is not clear whether 
the beneficial effects of CoQ10 is only limited to its 
antioxidant property, we and others have reported 
that CoQ10 prevents apoptosis activated upon 
mitochondrial dysfunction [29-35]. Similarly, 
evidence of CoQ10 against glutamate-induced cell 
death is lacking. Therefore, in the present study we 
investigated whether CoQ10 curtails glutamate 
toxicity, prevents cell death, and offers 
neuroprotective role. Further, we also explored 
whether the beneficial effects of CoQ10 against 
glutamate toxicity are mediated through regulating 
calcium fluctuations, mPTP formation, mitochondrial 
membrane potential, and mitochondrial dynamic 
balance. Water-soluble CoQ10 (aka Ubisol-Q10) was 
developed to overcome low bioavailability of 
traditional oil-soluble CoQ10 when taken orally [36]. 
Because traditional oil-soluble CoQ10 has a low 
bioavailability when taken orally, we decided to use 
the water soluble Q10 (aka Ubisol-Q10) for the present 
study. Ubisol-Q10 has better bioavailability and 
increases cellular and mitochondrial uptake by 20 to 
30 fold over the oil-soluble formulation. In addition, it 
is able to pass through the Blood-Brain Barrier (BBB) 
[37, 38]. Our data indicates that glutamate challenge 
induces mitochondrial dysfunction through ROS 
generation and mitochondrial membrane potential 
alteration. This further activates mitochondrial fission 
that results in mitochondrial fragmentation and mPTP 
formation. These events lead to AIF nuclear 
translocation, DNA fragmentation, and cell death. 
Ubisol-Q10 pre-treatment prevents mitochondrial 
dysfunction, stabilizes the mitochondrial membrane 
potential, blocks mPTP formation, prevents AIF 
nuclear translocation and nuclear DNA 
fragmentation, and subsequent cell death. These 
results clearly indicate that Ubisol-Q10 offers 
neuroprotective benefits partly through preserving 
mitochondrial dynamic balance and function and 
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preventing apoptotic cell damage. 
Materials and Methods  
Cell culture, experimental treatments and 
viability assays 
Murine hippocampal HT22 neuronal cells were 
cultured in Dulbecco's Modified Eagle Medium 
(DMEM, Invitrogen) supplemented with 10% 
heat-inactivated fetal bovine serum (FBS), 2 mM 
glutamine, and 200 mM streptomycin/penicillin 
(Invitrogen) and maintained at 90%-95% relative 
humidity in 5% CO2 at 37 °C. Glutamate (Sigma) and 
Ubisol-Q10 (Zymes LLC) were dissolved in water. 
The stock solutions were diluted with cell culture 
medium for each experiment. Cells were subjected to 
glutamate stress 24 h after Ubisol-Q10 treatment. 
Varying concentrations (1-5 mM) of glutamate [5] and 
Ubisol-Q10 (10-25 µg) were tested and evaluated for 
cell viability after 24 h of treatment. Quantification of 
cell viability in HT22 cells was performed in 96-well 
plates with 3-(4,5-dimethylthiazol-2-yl)-2,5-dip-
henyltetrazolium bromide (MTT) assay. HT22 cells 
were seeded at a density of 10,000 cells per well. After 
24 h of treatment, cells in each well were incubated 
with 10 μl MTT (5 mg/ml) at a final concentration of 
500 μg/ml. After 2 h the medium was removed from 
the wells and formazan formed was dissolved in 
dimethyl sulfoxide (DMSO, 80 μl). The absorbance 
was read with a dual-monochromator, 
multi-detection microplate reader (SpectraMax M5 
Molecular Device, Sunnyvale, CA) at 540 nm. Cell 
viability was expressed as a percent of the control. 
For drug treatment, antioxidant Trolox, 
hydrogen peroxide (H2O2), staurosporine, 
cyclosporine, and sodium azide were used to 
delineate the effects of Ubisol-Q10. 
Detections of ROS levels and calcium 
retention capacity  
Intracellular superoxide anion production was 
determined using dihydroethidium (DHE) as a 
fluorescent probe. Briefly, cells (2x106/ml) were 
incubated with the DHE (2.5 μM) for 30 min at 37ºC, 
after which they were washed, resuspended in 
phosphate buffered saline (PBS), and analyzed for 
fluorescent signal intensity using Fluoromax-4 
spectrofluorometer at the excitation and emission 
wavelengths of 480 nm and 590 nm respectively. The 
florescence was recorded and represented as relative 
fluorescence intensity (RFI). 
For measuring calcium retention capacity of the 
mitochondria, HT22 cells (5×106) were harvested, 
washed with PBS and permeabilized immediately 
with digitonin (50 µg/ml) for 2 min at 25°C in a Ca2+ 
free KCl medium (125 mM KCl, 2 mM K2HPO4, 1 mM 
MgCl2, 20 mM HEPES, pH 7.0) [37] Measurements of 
Ca2+ were performed fluorimetrically at 37°C with a 
FluoroMax-4 spectrofluorometer equipped with 
magnetic stirring and thermostatic controls. 
Extra-mitochondrial Ca2+ was measured in the 
presence of 1 µM Calcium Green-5N, 10 mM 
glutamate, 0.5 mM malate or 10mM succinate with 
excitation and emission wavelengths set at 506 and 
530 nm respectively. The free calcium (Ca2+) uptake 
and Ca2+ release of digitonin-permeabilized cells were 
measured by loading cells with Ca2+ pulses at 
constant time intervals. 
Measurement of mitochondrial membrane 
potential 
Mitochondrial membrane potential was 
measured using JC-1 dye. JC-1 exhibits 
potential-dependent accumulation in mitochondria 
with a fluorescence emission shift from green (~529 
nm) to red (~590 nm). Briefly, HT22 cells were grown 
on Lab-Tek II Chamber Slide (Thermo Scientific) and 
incubated with JC-1 dye (5 µg/ml). JC-1 was excited at 
488 nm and emission of JC-1 monomer (depolarized) 
and J-aggregate (polarized mitochondria) forms were 
captured at 525/50 and 605/75 nm, respectively, with 
Nikon laser-scanning confocal microscope (Nikon 
Eclipse C1). To avoid the photobleaching, laser power 
was attenuated to the minimal level. Minimum three 
fields per group were captured to determine the 
changes in mitochondrial membrane potential. 
Carbonylcyanide p-trifluoromethoxyphenylhydra-
zone (FCCP 5 µM) was used as a control to dissipate 
mitochondrial potential.  
Subcellular fractions and Immunoblotting 
 Mitochondrial and cytosolic fractions were used 
in the study and the fractions were isolated as 
described previously [5]. Briefly, cells were washed 
with PBS and resuspended in cytosolic lysis buffer 
(250 mM sucrose, 70 mM KCl, 137 mM NaCl, 4.3 mM 
Na2HPO4, 1.4 mM KH2PO4 pH 7.2, 200 μg/ml 
digitonin, 100 mM PMSF, protease inhibitor cocktail 
(Halt, Thermo Scientific) for 5 min on ice. These cells 
were centrifuged at 1,000 × g for 5 min to separate the 
supernatant as a cytosolic fraction and the pellet was 
resuspended in two volumes of mitochondrial lysis 
buffer (50 mM Tris-HCl pH 7.4, 150 mM NaCl, 2 mM 
EDTA, 2 mM EGTA, 0.2% (v/v) Triton X-100, 0.3% 
NP-40, PMSF, protease inhibitor cocktail) for 5 min on 
ice. The resulting suspension was centrifuged at 
10,000 × g for 10 min and the supernatant was 
collected as the mitochondrial fraction. The purity of 
the fractions has been previously verified [39]. Protein 
concentration was determined using the Bradford 
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assay and same amount of protein (20 µg) was loaded 
into each lane of a 4-12% NuPAGE gel (Invitrogen). 
Following electrophoresis, proteins were transferred 
to a nitrocellulose membrane (Invitrogen) and 
blocked for nonspecific binding with 5% skim milk. 
The membrane was incubated for target proteins 
using primary antibodies specific for Drp1 (1:1000, 
8570, Cell Signaling USA), phospho-Drp1 (Ser616 
1:800, 3455, Cell Signaling USA), Fis1 (1:500, sc-98900, 
MBL,MA USA), AIF (1:500, sc-9416, Santa Cruz 
Biotechnology, CA, USA), cytochrome C (1:500, 
sc-13560, Santa Cruz Biotechnology, CA, USA), 
VDAC (1 µg/ml ab14744, Abcam Inc, MA, USA) or 
Actin (1:1000,sc-1616, Santa Cruz Biotechnology, CA, 
USA) overnight at 4°C. The membranes were 
incubated with horseradish peroxidase-conjugated 
secondary antibodies for 1 h at room temperature. The 
blots were then developed using the Pierce ECL 
Western Blotting Substrate (Thermo Scientific). The 
β-actin or VDAC bands were used as internal loading 
controls and the ratios of the targeted proteins and 
loading control were calculated and presented as final 
results. 
Mitochondrial morphometrics 
HT22 cells were grown on Lab-Tek II Chamber 
Slide (Thermoscientific). Mitochondrial staining was 
carried out with MitoTracker®Red CM-XRos 
(Invitrogen) as described previously [5]. DAPI was 
used to label nuclei. Minimum 3 images were 
captured in each well for analyses using the Nikon 
laser-scanning confocal microscope at the 
magnification of 63X. An image process program was 
designed to identify and quantify mitochondria 
structures from the RGB images according to the 
published method [40, 41]. In brief, we first created a 
mask to filter out the nucleus regions that are mostly 
blue. Next, we extracted only the red channel and 
converted it to a gray-scale image. The resulting 
image was adjusted to increase contrast. A "top-hat" 
spatial filter was applied in order to isolate bright 
features from a dark background using a flat, 
disk-shaped structuring element with a radius of 2 
pixels. In order to reduce noise while preserving 
edges, a 2-D median filtering with a dimension of 3 x 3 
pixels was applied twice. An additional threshold was 
applied to remove darker pixels.  
For morphological analysis, three parameters 
were calculated for each mitochondrial object: the 
form factor F (perimeters2/(4π• area)), mitochondrial 
perimeter and mitochondrial area. We also computed 
the total number of mitochondria per cell. Form factor 
is independent of image magnification and has a 
minimum value of 1 (corresponding to a perfect 
circle). For statistical analysis, we calculated the 
average values of F for each image. 
AIF immunostaining 
HT22 cells were grown on Lab-Tek II Chamber 
Slides (Thermo Scientific). Cells were fixed 18 h after 
glutamate exposure with 4% paraformaldehyde for 
20 min, washed with PBS, and permeabilized in 
Triton X-100 (0.3%) for 5 min. The cells were blocked 
with 10% donkey serum for 1 h at room temperature. 
After blocking, cells were incubated overnight at 4°C 
with primary antibodies against AIF (1:200, Santa 
Cruz Biotechnology CA). Cells were washed and 
incubated for 2 h at room temperature with secondary 
antibodies conjugated with Alexa Fluor 488 (1:500 
dilution; Invitrogen). Finally, slides were mounted 
with Vectashield mounting medium containing DAPI 
(Vector Laboratories). Slides were scanned with a 
Nikon laser-scanning confocal microscope. The 
experiment was repeated thrice and, at minimum, 
three fields per group were captured and processed 
for analysis. 
DNA fragmentation assay 
DNA fragmentation due to apoptosis was 
assessed by terminal deoxynucleotidyl transferase- 
mediated dUTP nick-end-labeling (TUNEL) assay 
using a DeadEnd Fluorometric TUNEL system kit 
(Promega, USA) per the kit instructions. A minimum 
of three random fields per group were captured. 
TUNEL positive cells were counted and presented as 
percent of total cells.  
Statistical analysis 
Data are presented as mean±SD and analyzed 
with GraphPad Prism 5 software. One-way ANOVA 
followed by Tukey’s multiple comparison test and 
two-way ANOVA followed by Bonferoni test were 
used when appropriate. A p<0.05 is considered 
statistically significant. 
Results 
Pretreatment of HT22 cells with Ubisol-Q10 
blocked glutamate-induced cell death 
To determine the neuroprotective role of Q10, 
we exposed Ubisol-Q10 pretreated and untreated 
HT22 neuronal cells to glutamate and cell survival 
was determined by MTT assay and cellular 
morphology (Fig. 1). Glutamate induced cell death in 
HT22 cells in a dose (data not shown) and time 
dependent manner [5]. Therefore, the cell survival 
was limited to around 20 % of control (Fig. 1A and B) 
with 4 mM of glutamate after 24 h of exposure [5]. In 
contrast, Ubisol-Q10 alone up to the 25 µg/ml range 
was well tolerated by HT22 neurons without any 
influence on cell viability (Fig. 1A). Interestingly, 
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Ubisol-Q10 (10-25 µg/ml) blocked glutamate-induced 
death in HT22 cells; thereby significantly (p<0.001) 
improved the cell survival (from 21 to 87 %) of control 
HT22 cells (Fig. 1A and B). The Ubisol-Q10-induced 
protection was not transiently limited to 24 h as the 
rescue effects were also noticed up to 48 h of 
glutamate exposure (data not shown), suggesting the 
long-term protective effect of Ubisol-Q10. 
Ubisol-Q10 decreased ROS levels and 
stabilized mitochondrial membrane potential 
We have previously shown that glutamate 
exposure alters ROS levels and mitochondrial 
membrane potential [5]. In the present study, we set 
the baseline level of ROS production in control cells as 
100%. Exposure of HT22 neurons to glutamate 
resulted in enhanced ROS formation when measured 
after 18 h (p<0.05). Presently, we determined whether 
Ubisol-Q10 treatment could prevent the increase in 
ROS production and whether this effect is associated 
with stabilizing mitochondrial potential (Fig. 2). 
Results revealed that glutamate induced the 
generation of ROS whereas Ubisol-Q10 treatment 
curtailed it (Fig. 2A).  
Likewise, glutamate also affected mitochondrial 
membrane potential. Glutamate exposure resulted in 
membrane depolarization as reflected by the increase 
in green fluorescence of JC-1 monomer. Pretreatment 
with Ubisol-Q10 prevented glutamate-induced 
mitochondrial membrane depolarization as reflected 
by the predominant red fluorescence of JC-1 
aggregates that were taken by normal polarized 
mitochondria. Non-treated control cells and cells 
treated with Ubisol-Q10 alone maintained normal 
mitochondrial potential (Fig. 2B).  
To determine whether glutamate-induced cell 
death is mediated by increased free ROS production 
and loss of mitochondrial potential through formation 
of mPTP, we used free radical scavenger Trolox and 
Cyp-D /ANT channel inhibitor cyclosporine. Cell 
viability study results revealed that Trolox 
significantly ameliorated glutamate toxicity (Fig. 2C), 
while cyclosporine A failed to prevent glutamate 
induced cell death in HT22 cells (Data not shown). 
These results suggest that glutamate-induced cell 
death is mediated through formation of ROS and 
mPTP independent of Cyp-D /ANT. 
Ubisol-Q10 prevented glutamate-reduced 
calcium retention capacity  
Mitochondria have been shown to transiently 
store calcium and thereby regulating cellular 
Ca2+ homeostasis. Reduction or loss of calcium 
retention capacity of the mitochondria leads to 
formation of mPTP and opening of mPTP has been 
shown to be a primary mediator of cell death. We 
investigated whether glutamate lowers calcium 
retention capacity and whether Ubisol-Q10 could 
improve it. Mitochondrial calcium uptake capacity 
was detected using Calcium Green-5N. Addition of 
calcium causes increase in extra-mitochondrial 
calcium and then the concentration decreased as the 
calcium is taken up by the mitochondria. Under 
normal condition, cells with Ubisol-Q10 addition did 
not differ in mitochondrial calcium uptake capacity as 
compared to control cells. After glutamate exposure, 
calcium retention capacity was decreased compared 
to control cells. Ubisol-Q10 pretreatment in 
glutamate-exposed cells restored the calcium 
retention capacity to control level (Fig. 3). 
 
 
Figure 1: Ubisol-Q10 blocks glutamate toxicity-induced cell death. (A) Concentration-dependent effect of water soluble Ubisol-Q10 on HT22 cell viability alone and 
with 4 mM glutamate. Ubisol-Q10 was added to the cell media prior to the glutamate exposure and cell viability was estimated 24 h after addition. Ubisol-Q10 alone upto 25 µg 
had no effect on cell viability whereas glutamate exposure significantly reduced the survival of cells to nearly 20 % of control. Pretreatment of cells with Ubisol-Q10 resisted the 
effect of glutamate toxicity thereby showed significant reduction in cell mortality. Ubisol-Q10 concentration of 15 μg showed maximum protection to glutamate induced cell 
death in HT222 cells. (B) Representative photomicrograph of HT22 cells treated with Ubisol-Q10, glutamate and both. Data are the representation of 3 or more independent 
experiments conducted in triplicate. Values are means±SD and analyzed by one-way ANOVA followed by Tukey's multiple comparison test. Significant levels is shown by 
***=p<0.001 vs. respective group. Glu=glutamate, Q10=Ubisol-Q10, Glu+Q10=glutamate +Ubisol-Q10 and Glu+Q10-15 to 25 = glutamate (4 mM) +Ubisol-Q10 (15-25 µg). 
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Figure 2: Ubisol-Q10 prevents glutamate induced ROS production and mitochondrial potential loss. (A) ROS production were measured using DHE in 
Ubisol-Q10 pretreated HT22 cells exposed to glutamate. Ubisol-Q10 normalized the glutamate exposure increased levels of ROS. (B) Micrograph of HT22 cells shows potential 
loss after glutamate exposure (arrow). Ubisol-Q10 pretreatment prevented glutamate induced depolarization of mitochondrial membrane potential. Mitochondrial potential 
measured with JC-1, shows red staining as normal potential whereas green staining represents depolarization and potential loss. (C) Summarized graph shows the effect of 
Antioxidant Trolox and Ubisol-Q10 on glutamate-induced cell death. Data are the representation of 3 or more independent experiments conducted in triplicate. Values are 
means±SD and analyzed by one-way ANOVA followed by Tukey's multiple comparison test. Significant levels is shown by *=p<0.05 and ***=p<0.001 vs. respective group. 
Glu=glutamate, Q10=Ubisol-Q10 and Glu+Q10 = glutamate+Ubisol-Q10. 
 
Figure 3: Ubisol-Q10 restores glutamate 
reduced mitochondrial calcium retention 
capacity. Figures show cytosolic calcium uptake by 
mitochondrial in permeabilized HT22 cells. The 
addition of calcium (cytosolic) indicated by an arrow 
(25 µM of calcium pulse each) results in a rapid 
increase in signal that subsequently decline due to 
calcium uptake by mitochondria. Result shows that 
glutamate exposure reduced the capacity of 
mitochondrial to uptake cytosolic excessive calcium. 
Ubisol-Q10 pretreatment in contrast improved the 
mitochondrial calcium uptake to normal levels, 
thereby maintained the mitochondrial calcium 
uptake capacity. Cont=Control, 
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Ubisol-Q10 inhibits glutamate-induced 
mitochondrial fragmentation 
Previously, we have shown that glutamate 
affects mitochondrial morphology in HT22 cell by 
increasing mitochondrial fission, which may leads to 
increased ROS formation, loss of mitochondrial 
potential and calcium retention capacity, and 
adversely affects mitochondrial function [5]. We 
investigated whether the protective effects of 
Ubisol-Q10 is mediated through preventing 
mitochondrial fragmentation. Mitochondria are 
organized as a tubular network under normal control 
conditions. Under stress conditions, mitochondrial 
fission occurs and the reticular mitochondria break 
into short, round pieces, a process defined as 
mitochondrial fragmentation. Mitochondrial fission 
markers Drp1 and Fis1 were measured using 
immunoblotting. Drp1 is normally present in the 
cytosol of the cell, but when phosphorylated at 
Ser616, Drp1 translocates to the mitochondria and 
stimulates mitochondrial fission. The results showed 
that phospho-Drp1 and Fis1 were significantly 
increased in the mitochondrial fraction, but not in the 
cytosolic fraction, after 18 h of glutamate exposure. 
Treatment with Ubisol-Q10 completely blocked the 
phosphorylation of Drp1 and the increase in Fis1 
(Fig. 4). 
Consistent with the protein levels of Drp1 and 
Fis1, mitochondrial imaging study using MitoTracker 
Red revealed that the glutamate caused marked 
mitochondrial morphologic alteration. As seen in 
Figure 5, the reticularity of the mitochondrial network 
was broken into small round shaped mitochondrial 
pieces after 18 h of glutamate exposure. Pretreatment 
with Ubisol-Q10 restored the mitochondrial tubular 
network in glutamate-exposed cells (Fig. 5A).  
 
 
Figure 4. Ubisol-Q10 inhibits glutamate-induced change mitochondrial fragmentation markers. Representative Western blots and quantitative analysis of the 
protein band of mitochondrial fission protein Drp1, pDrp1 and Fis1. Glutamate exposure significantly increased the levels of mitochondrial fragmentation markers Drp1, pDrp1 
and Fis1 without affecting the levels of VDAC and cytochrome c release after 18 h. Ubisol-Q10, in contrast blunted the corresponding elevation of Drp1, pDrp1 and Fis1 in these 
cells, thereby Ubisol-Q10 significantly prevented the glutamate-induced increase in these markers. Data are the representation of 3 or more independent experiments conducted 
in triplicate. Values are means±SD and analyzed by one-way ANOVA followed by Tukey's multiple comparison test. Significant levels is shown by *=p<0.05, **=p<0.01 and 
***=p<0.001 vs. respective group. Glu=glutamate and Q10=Ubisol-Q10. 
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Figure 5. Ubisol-Q10 preserved mitochondrial morphology. (A) Photomicrograph shows mitochondrial morphology in HT22 cells treated with glutamate and 
Ubisol-Q10. Mitochondrial morphology was studied using MitoTracker Red with confocal microscopy. Images were processed and analyzed for structural alterations. Glutamate 
exposure (18 h) decreased the mitochondrial reticular network resulting into small round shaped broken mitochondria. Ubisol-Q10 pretreatment restored the mitochondrial 
tubular network in glutamate-exposed cells. (B) Figure shows mitochondrial perimeter and form factor (branching) analyzed from the mitochondrial micrograph. Glutamate 
exposure not only lowered the mitochondrial perimeter but also reduced the mitochondrial branching. Ubisol-Q10 pretreatment blocked these effects of glutamate and thereby 
restored normal mitochondrial morphology. Data are the representation of 3 or more independent experiments conducted in triplicate. Values are means±SD and analyzed by 
one-way ANOVA followed by Tukey's multiple comparison test. Significant levels is shown by *=p<0.05 and **=p<0.01 vs. respective group. Glu=glutamate and 
Q10=Ubisol-Q10. 
 
To determine the effects of glutamate exposure 
on mitochondrial morphology and the degree of 
mitochondrial network branching in cells treated 
with/without Ubisol-Q10, we determined the 
mitochondrial perimeter and form factor (branching). 
The result revealed that glutamate significantly 
(p<0.05) lowered the mitochondrial perimeter in 
HT22 cells (Fig. 5B). Pretreatment with Ubisol-Q10 
restored the mitochondrial perimeter in 
glutamate-exposed cells. Similarly, glutamate 
exposure markedly affected the network of 
mitochondria. Mitochondrial was significantly 
(p<0.05) less branched in cells exposed to glutamate. 
When pretreated with Ubisol-Q10, cells recovered 
from glutamate toxicity and restored the form factor, 
which clearly suggests that Ubisol-Q10 improve 
cellular mitochondrial function by protecting 
mitochondrial morphology (Fig. 5B). 
Ubisol-Q10 blocks mitochondrial 
dysfunction-induced release of AIF 
Glutamate-induced cell death in HT22 cells have 
been shown to be mediated by AIF dependent 
apoptosis [42, 43]. Formation of mPTP may lead to 
release of mitochondrial proapoptotic proteins such 
as AIF and others. To examine whether 
glutamate-induced mitochondrial fragmentation 
caused release of proapoptotic proteins and whether 
restoration of mitochondrial structure by Ubisol-Q10 
could block the release of mitochondrial proteins, we 
measured the levels of cytochrome c protein levels in 
mitochondrial and cytosolic fractions, AIF protein in 
mitochondrial and nuclear fractions and AIF 
immunoreactivity (Fig 6). The results demonstrated 
that cytochrome c was not released from the 
mitochondria into the cytosol (Fig 4). However, AIF 
immunocytochemistry showed nuclear localization of 
AIF after glutamate treatment in HT22 cells and 
treatment with Ubisol-Q10 significantly blocked the 
AIF presence in the nuclei (Fig 6B). These results were 
further confirmed by immunoblotting that showed a 
significant increase of AIF protein in the nuclear 
fraction after glutamate exposure and the AIF level 
was markedly reduced by Ubisol-Q10 (Fig 6A). 
Ubisol-Q10 reduces glutamate-induced 
apoptotic injury 
Detection of apoptotic cell death by TUNEL 
staining revealed that incubation of cells with 4 µM 
glutamate for 18 h significantly increased the number 
of TUNEL-positive stained cells (Fig. 7). The average 
percent of TUNEL positive cells reach to 38.7±17.9%. 
In contrast, the number of TUNEL positive cell in 
glutamate-exposed cells was significantly (p<0.05) 
reduced by Ubisol-Q10 treatment. As a result, the 
number of TUNEL positive cells reduced to 
Int. J. Biol. Sci. 2016, Vol. 12 
 
 
http://www.ijbs.com 
696 
non-glutamate control level. Few TUNEL positive 
cells were observed in non-treated control cells and 
with Q10-treatment alone. A panel of TUNEL-stained 
images is shown in Figure 7B and percent of TUNEL 
positive cells in each group is given in Figure 7B. 
 
 
Figure 6: Ubisol-Q10 prevented glutamate-induced AIF release. (A) Representative Western blots and quantitative analysis of the protein bands of AIF in 
mitochondrial and nuclear fractions. AIF levels were relatively similar in HT22 cells treated with glutamate and Ubisol-Q10 in mitochondrial fraction. In contrast, glutamate 
exposure significantly increased AIF nuclear translocation. Ubisol-Q10 pretreatment blocked the AIF nuclear translocation in cell exposed to glutamate. (B) Photomicrograph 
and quantitation of AIF positive cells. Cells shows peripheral punctuated staining in control untreated and Ubisol-Q10 only treated cells. AIF translocates to the nucleus following 
glutamate exposure as shown by diffused staining. Ubisol-Q10 blocked AIF nuclear translocation. Data are the representation of 3 or more independent experiments conducted 
in triplicate. Values are means±SD and analyzed by one-way ANOVA followed by Tukey's multiple comparison test. Significant levels is shown by **=p<0.01 and ***=p<0.001 vs. 
respective group. Cont=Control, Glu=glutamate and Q10=Ubisol-Q10. 
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Figure 7: Ubisol-Q10 prevented DNA damage in cells treated with glutamate. Photomicrograph and quantitation of cells with DNA fragmentation determined with 
TUNEL staining. Glutamate increased the number of cells positive for TUNEL measure after 18 h of exposure. Ubisol-Q10 in contrast prevented the DNA fragmentation in cells 
exposed to glutamate. Data are the representation of 3 or more independent experiments conducted in triplicate. Values are means±SD and analyzed by one-way ANOVA 
followed by Tukey's multiple comparison test. Significance is shown by *=p<0.05 vs. respective group. Cont=Control, Glu=glutamate and Q10=Ubisol-Q10. 
 
Discussion 
Mitochondrial dysfunction due to various 
reasons including oxidative stress plays a crucial role 
in activation of cell death pathways. Recently, we 
have shown that mitochondrial dysfunction could be 
the result of mitochondrial fragmentation induced by 
glutamate toxicity [5] and glutamate toxicity is a key 
step in the progression of neuronal loss in acute and 
chronic neurodegenerative diseases. CoQ10, in 
addition to carrying electrons during oxidative 
phosphorylation, positively influence many cellular 
functions presumably due to its antioxidant property 
[29, 32, 33, 44]. Although, it is not clear whether the 
beneficial effects of CoQ10 is only limited to its 
antioxidant property, we and others have reported 
that CoQ10 also prevent mitochondrial 
dysfunction-induced activation of apoptosis [29-32, 
34, 35]. Presently we demonstrate that glutamate 
causes mitochondrial fragmentation, mPTP 
formation, calcium deregulation and mitochondrial 
potential loss. These events lead to AIF nuclear 
translocation, DNA fragmentation, and cell death. 
Ubisol-Q10 pretreatment prevented 
glutamate-induced cell death by blocking 
mitochondrial fragmentation, ameliorating 
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mitochondrial dysfunction, stabilizing the 
mitochondrial membrane potential, blocking the 
mPTP formation, and preventing the AIF nuclear 
translocation and DNA fragmentation. These results 
clearly indicate that Ubisol-Q10 offers 
neuroprotective benefits partly through preserving 
mitochondrial structure and function, which thereby 
prevents cell damage. 
In the present study, we have shown that 
glutamate induces cell death in HT22 cells through 
oxidative stress, mitochondrial dysfunction and AIF 
release [5, 9, 42, 43, 45, 46]. Glutamate-induced 
mitochondrial dysfunction could be the result of 
mitochondrial fragmentation due to activation of 
Drp1 as reported previously [5]. The fragmented 
mitochondria are sensitized to Bax/Bid-dependent 
pore formation and activation of apoptosis [16, 47, 48]. 
Drp1 is normally present in the cytosol, but once 
phosphorylated at Ser616, it translocates to the 
mitochondria where it localizes to potential division 
sites on mitochondrial outer membrane with the help 
of Fis1. In the present study, we show that glutamate 
exposure not only increased the levels of Fis1 but also 
increased the phosphorylation and mitochondrial 
translocation of Drp1 (Fig. 4), which is consistent with 
our previous finding [5]. Increased mitochondrial 
Drp1 levels were well correlated with the 
mitochondrial morphology (Fig. 4 and 5), suggesting 
that Drp1 induces mitochondrial fragmentation in 
cells exposed to glutamate. Likewise, mitochondrial 
fragmentation has been shown to be associated with 
increased oxidative stress and mitochondrial 
depolarization, whereas inhibiting Drp1 offers 
neuroprotection [43, 47].  
Glutamate toxicity can also trigger calcium 
influx that leads to mitochondrial calcium overload 
[12] whereas, once fragmented, mitochondria reduce 
their calcium buffering capacity [49]. Our study 
showed that glutamate-exposed cells exhibited 
impaired mitochondrial calcium loading capacity, AIF 
nuclear translocation, DNA fragmentation, and cell 
death (Fig. 3, Fig. 6 Fig. 7 and Fig. 1). It is likely that 
mitochondrial calcium overload alone or in 
combination with increased ROS production, triggers 
the formation of mPTP that results in the activation of 
cell death pathway. Additionally, it is believed that 
glutamate-mediated oxidative stress due to increased 
ROS production has been shown to be a biphasic 
event in a way that glutamate induces a primary 
surge in ROS production after 6-8 h and followed by a 
secondary boost after 18 h [43]. The primary ROS 
could be ascribed to glutamate induced glutathione 
depletion as proposed previously [50], whereas the 
secondary boost in ROS production could be the 
result of mitochondrial fragmentation due to the 
activation of Drp1. 
Furthermore, presently we showed that 
glutamate-induced cell death could be prevented with 
the supplementation of Ubisol-Q10 (Fig. 1). CoQ10, 
which is an endogenous electron carrier in the inner 
mitochondrial membrane, has been widely studied 
for its antioxidative properties [29, 44]. Moreover, 
Papucci et al. have reported that CoQ10 could also 
prevent apoptosis in response to apoptotic stimuli 
that do not generate free radicals [35]. We and others 
have previously shown that cells death mechanism in 
HT22 cells are activated due to mitochondrial 
dysfunction [5, 9, 42, 43] and mitochondrial 
dysfunction could be the result of mitochondrial 
fragmentation caused by Drp1. Inhibiting Drp1 
improves the survival of cells in vitro and in vivo 
conditions of glutamate toxicity [45]. We presently 
reported that Ubisol-Q10 blocked Drp1 mitochondrial 
translocation and thereby reduced mitochondrial 
fragmentation upon glutamate exposure. 
Mitochondria appeared tubular and branched in cells 
treated with Ubisol-Q10 and Ubisol-Q10+glutmate. 
Whereas, mitochondria appeared small and rounded 
in glutamate only treated cells. Fragmented 
mitochondria are not only prone to increased 
oxidative stress and depolarization [51] but also are 
sensitized to proapoptotic Bcl-2 family protein 
mediated pore formation [16, 47, 48]. We found that 
Ubisol-Q10 supplementation not only blocked 
increase in ROS production but also prevented 
mitochondrial potential loss upon glutamate exposure 
(Fig 2, Fig. 4 and Fig. 5). Therefore, cells treated with 
Ubisol-Q10 resisted glutamate-induced decreases of 
mitochondrial perimeter and mitochondrial 
branching, and maintained normal mitochondrial 
morphology (Fig. 4 and 5). Although, it is not clear 
from the present study whether Ubisol-Q10 directly 
blocks mitochondrial fragmentation by inhibiting 
Drp1 or whether Ubisol-Q10 prevents the primary 
surge in ROS production which is responsible for 
Drp1 activation and mitochondrial fragmentation, 
CoQ10 has been suggested to prevent mitochondrial 
depolarization independent to its antioxidant 
property [35]. In the present study, we also showed 
that Ubisol-Q10 has a slightly better effect on cell 
survival than antioxidant Trolox (Fig. 2C). Moreover, 
evidence indicates that ROS production could be 
increased following mitochondrial fragmentation [52]. 
By blocking mitochondrial fragmentation, Ubisol-Q10 
treatment may lower ROS production and prevent the 
mitochondrial depolarization. Mitochondrial 
depolarization is an indicator of mPTP formation 
during various stresses that reduce mitochondrial 
calcium retention capacity [50]. Glutamate exposure 
in the present study decreased mitochondrial calcium 
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capacity, whereas Ubisol-Q10 pretreatment restored 
capacity and ultimately improved cell survival in cells 
exposed to glutamate (Fig. 3, Fig. 6 and Fig. 1). 
Likewise, mitochondrial fragmentation reduces the 
mitochondrial calcium retention capacity and aids in 
formation of mPTP though which proapoptotic 
protein are released. Therefore, the present study 
reveals that Ubisol-Q10 directly or indirectly blocks 
Drp1 dependent mitochondrial fragmentation, 
prevents mitochondrial potential loss and mPTP 
formation, restores mitochondrial calcium capacity, 
and inhibits AIF release and apoptotic DNA 
fragmentation, and thereby improves survival in cells 
exposed to glutamate. All the evidence supports that 
Ubisol-Q10 offers beneficial effects by preserving 
mitochondrial structure and function.  
Conclusion 
Glutamate causes cell death by inducing 
mitochondrial fragmentation and dysfunction, 
formation of mPTP, and nuclear translocation of AIF. 
Ubisol-Q10 prevents glutamate-induced cell death by 
blocking mitochondrial fragmentation, preserving 
mitochondrial calcium retention capacity and 
membrane potential, preventing mPTP formation, 
AIF release, and DNA fragmentation. Ubisol-Q10 
supplementation may be beneficial in ameliorating 
stroke, brain and spinal traumatic injuries, 
mitochondria-associated neurodegenerative and 
metabolic disorders.  
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